Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,100 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effects of cyclodextrin in two patients with Niemann-Pick Type C disease.
Matsuo M, Togawa M, Hirabaru K, Mochinaga S, Narita A, Adachi M, Egashira M, Irie T, Ohno K. Matsuo M, et al. Among authors: irie t. Mol Genet Metab. 2013 Jan;108(1):76-81. doi: 10.1016/j.ymgme.2012.11.005. Epub 2012 Nov 15. Mol Genet Metab. 2013. PMID: 23218948
Reply: lung toxicity of hydroxyl-β-cyclodextrin infusion.
Matsuo M, Arima H, Irie T. Matsuo M, et al. Among authors: irie t. Mol Genet Metab. 2013 Jun;109(2):233. doi: 10.1016/j.ymgme.2013.04.010. Epub 2013 Apr 23. Mol Genet Metab. 2013. PMID: 23660393 No abstract available.
Efficacy of 2-Hydroxypropyl-β-cyclodextrin in Niemann-Pick Disease Type C Model Mice and Its Pharmacokinetic Analysis in a Patient with the Disease.
Tanaka Y, Yamada Y, Ishitsuka Y, Matsuo M, Shiraishi K, Wada K, Uchio Y, Kondo Y, Takeo T, Nakagata N, Higashi T, Motoyama K, Arima H, Mochinaga S, Higaki K, Ohno K, Irie T. Tanaka Y, et al. Among authors: irie t. Biol Pharm Bull. 2015;38(6):844-51. doi: 10.1248/bpb.b14-00726. Biol Pharm Bull. 2015. PMID: 26027824 Free article.
2-Hydroxypropyl-β-Cyclodextrin Acts as a Novel Anticancer Agent.
Yokoo M, Kubota Y, Motoyama K, Higashi T, Taniyoshi M, Tokumaru H, Nishiyama R, Tabe Y, Mochinaga S, Sato A, Sueoka-Aragane N, Sueoka E, Arima H, Irie T, Kimura S. Yokoo M, et al. Among authors: irie t. PLoS One. 2015 Nov 4;10(11):e0141946. doi: 10.1371/journal.pone.0141946. eCollection 2015. PLoS One. 2015. PMID: 26535909 Free PMC article.
Corrigendum to "In vitro evaluation of 2-hydroxyalkylated β-cyclodextrins as potential therapeutic agents for Niemann-pick type C disease" [Mol. Genet. Metab. (2016) 214-219].
Kondo Y, Tokumaru H, Ishitsuka Y, Matsumoto T, Taguchi M, Motoyama K, Higashi T, Arima H, Matsuo M, Higaki K, Ohno K, Irie T. Kondo Y, et al. Among authors: irie t. Mol Genet Metab. 2017 Mar;120(3):296-297. doi: 10.1016/j.ymgme.2016.09.004. Epub 2016 Oct 10. Mol Genet Metab. 2017. PMID: 27733311 No abstract available.
Influence of Npc1 genotype on the toxicity of hydroxypropyl-β-cyclodextrin, a potentially therapeutic agent, in Niemann-Pick Type C disease models.
Tanaka Y, Ishitsuka Y, Yamada Y, Kondo Y, Takeo T, Nakagata N, Higashi T, Motoyama K, Arima H, Matsuo M, Higaki K, Ohno K, Irie T. Tanaka Y, et al. Among authors: irie t. Mol Genet Metab Rep. 2014 Jan 11;1:19-30. doi: 10.1016/j.ymgmr.2013.12.003. eCollection 2014. Mol Genet Metab Rep. 2014. PMID: 27896072 Free PMC article.
1,100 results